Skip to main content

Aims and scope

Cardiovascular Diabetology considers manuscripts on all aspects of the diabetes/cardiovascular interrelationship and the metabolic syndrome; this includes clinical, genetic, experimental, pharmacological, epidemiological and molecular biology research.

© maurice norbert / Stock.adobe.comCardiovascular Diabetology appointed Dr. Pasquale Paolisso as Social Media Editor!
He will be selecting Cardiovascular Diabetology articles to be promoted on X each week based on highest quality of content and graphical abstract. Authors who want to promote their article in X are encouraged to tag Dr. Paolisso (@P_Paolisso) in their tweets.

Call for Papers: Perivascular adipose tissue: friend or foe in cardiometabolic disorders

Edited by:
Dr. Cristina Sena, PhD, University of Coimbra, Portugal

Submission Status: Open until 31 January 2025

Call for Papers: Cardiometabolic HFpEF with focus on type 2 diabetes mellitus

Edited by:
Professor Francesco Paneni, MD, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland                         

Dr. Era Gorica, PhD, Department of Cardiology and CTEC, University Hospital and University of Zürich, Switzerland


Submission Status: Open until 20 November 2024

Articles

  1. Authors: David Bode, Lukas Semmler, Paulina Wakula, Niklas Hegemann, Uwe Primessnig, Nicola Beindorff, David Powell, Raphael Dahmen, Hartmut Ruetten, Christian Oeing, Alessio Alogna, Daniel Messroghli, Burkert M. Pieske, Frank R. Heinzel and Felix Hohendanner

© Costantino, S., Mengozzi, A., Velagapudi, S. et al. Cardiovasc Diabetol 22, 312 (2023). https://doi.org/10.1186/s12933-023-02057-2Cardiovascular Diabetology strongly encourages authors to submit a graphical abstract along with their manuscript. 
Articles with graphical abstracts will be prioritized for social media promotion. 

2023 Editor's highlights

Click here for a selection of 2023 highlight articles published in Cardiovascular Diabetology.


From the blog

New Content ItemContinuous glucose monitoring
2 November, 2023

 

New Content ItemTransforming diabetes management: the adoption of technology as a game changer in diabetes care
1 November, 2023

New Content ItemThe most effective medication for weight loss and blood glucose stabilization: Tirzepatide
11 January 2023

Announcing the launch of In Review

Cardiovascular Diabetology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:

  • Share their work with fellow researchers to read, comment on, and cite even before publication
  • Showcase their work to funders and others with a citable DOI while it is still under review
  • Track their manuscript - including seeing when reviewers are invited, and when reports are received 

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115